At this time, posts about Shinpung Pharmaceutical are rapidly increasing on portals and securities communities. Today, foreigners have sold a net 34,000 shares of Shinpung Pharmaceutical, while institutions have bought a net 2,000 shares, according to preliminary data. Shinpung Pharmaceutical is known as a pharmaceutical company focused on the sales of specialized therapeutic drugs.


As of 12:30 PM on the 21st, Shinpung Pharmaceutical's stock price is 136,500 KRW, down 8.7% from the previous day, with a trading volume of 5,063,390 shares, which is 180.39% of the 5-day average trading volume. On December 11th, Shinpung Pharmaceutical became an issue in the market with the headline "3-month sales suspension causes double-digit plunge."


In addition to Shinpung Pharmaceutical, posts by investors are also rapidly increasing regarding Ilyang Pharmaceutical (007570), IA (038880), and Sambon Electronics (111870).



※Source: AI Investment Assistant AI Rasero


※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing